Induction chemotherapy with cisplatin plus weekly paclitaxel followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN): Single center experience in the south of Brazil.

Abstract

e17009 Background: The paclitaxel/cisplatin is a non-infusional alternative for induction chemotherapy of LASCCHN based on phase II trials. Here, we describe our institutional experience with this ...